Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

Once-Yearly Lenacapavir PrEP a Safe, Promising Alternative to Twice-Yearly Dosing

(MedPage Today) -- SAN FRANCISCO -- A once-yearly intramuscular lenacapavir (Sunlenca) injection was safe and well-tolerated and had higher median levels of plasma concentrations compared with twice-yearly subcutaneous lenacapavir for HIV pre...

This annual shot might protect against HIV infections

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Hope for HIV prevention: Annual injection completes important safety trial

Researchers develop method to identify dormant cells that carry HIV

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure for the infection affecting nearly 40 million people globally. The findings were published in Nature Communications.

Uganda: Annual HIV Prevention Jab Shows Promise - What It Means for Uganda

A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.